首页> 外文OA文献 >Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

【2h】

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

机译：乙酰半胱氨酸造影剂肾病（ACT）试验的原理，设计和基线特征：一项实用的随机对照试验，评估乙酰半胱氨酸预防造影剂引起的肾病的功效

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy [J] . Trials . 2009,第1期

机译：乙酰半胱氨酸造影剂肾病（ACT）试验的原理，设计和基线特征：一项实用的随机对照试验，评估乙酰半胱氨酸预防造影剂诱发的肾病的功效
2. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial [J] . Liu Yong, Chen Ji-yan, Huo Yong, The American heart journal . 2016,第Null期

机译：接受原发性经皮冠状动脉介入治疗以预防造影剂诱发的肾病（ATTEMPT）的ST抬高型心肌梗死患者的积极性水合作用：随机对照试验ATTEMPT RESCIND 1的研究设计和方案（第一个减少对症治疗的研究肾病跟心导管检查）试验
3. Aggressive hydraTion in patients with ST-Elevation Myocardial infarction undergoing Primary percutaneous coronary intervention to prevenT contrast-induced nephropathy (ATTEMPT): Study design and protocol for the randomized, controlled trial, the ATTEMPT, RESCIND 1 (First study for REduction of contraSt-induCed nephropathy followINg carDiac catheterization) trial [J] . Liu Yong, Chen Ji-yan, Huo Yong, The American heart journal . 2016,第Null期

机译：患有初级经皮冠状动脉干预的患者侵略性水合，以防止对比诱导的肾病（企图）：用于随机，对照试验的研究和议定书，尝试，RECCIND 1（第一次减少对比度诱导的研究心脏导管插入后的肾病）试验
4. Rationale, Design and Preliminary Results of ROMEO (Rethink Organization to Improve Education and Outcomes) A Randomized Controlled Multicenter Trial of Group Care in the Management ofType 1 Diabetes [C] . M. Porta, M. Trent European Association for the Study of Diabetes . 2005

机译：Romeo（重新思考组织改善教育和结果）的基本理由，设计和初步结果，在1型糖尿病的术语中进行了随机对照的组织的多中心试验
5. The association between baseline fructose consumption and baseline biomarkers of inflammation in a randomized controlled feeding trial. [D] . Luo, Ke. 2015

机译：在一项随机对照喂养试验中，基线果糖消耗与炎症基线生物标志物之间的关联。
6. Rationale design and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy [O] . 2009

机译：乙酰半胱氨酸造影剂肾病（ACT）试验的原理设计和基线特征：一项实用的随机对照试验评估乙酰半胱氨酸预防造影剂肾病的功效
7. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy [O] . null null 2009

机译：乙酰半胱氨酸造影剂肾病（ACT）试验的原理，设计和基线特征：一项实用的随机对照试验，评估乙酰半胱氨酸预防造影剂引起的肾病的功效

Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy

著录项

引文网络

相似文献

相关主题

期刊订阅